Home » Topics » Regulatory

Regulatory
RSS

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Aug. 4, 2003

No Comments

Use of amylin agonists for reducing triglyceride levels

Aug. 4, 2003

No Comments

FDA approval for Rebetol in pediatric hepatitis C

Aug. 4, 2003

No Comments

Antiemetic properties reported for known analgesic agent

Aug. 1, 2003

No Comments

Novel, more stable compositions of statin claimed

Aug. 1, 2003

No Comments

Bisphosphonates: methods for treatment of bone disorders claimed

July 31, 2003

No Comments

Factive receives expanded FDA approval

July 31, 2003

No Comments

FDA approves Humatrope for short stature

July 31, 2003

No Comments

Solid controlled-release formulations of known antidepressant

July 30, 2003

No Comments

Compositions of dextrin sulfate for STDs claimed by ML Laboratories

July 30, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Use of amylin agonists for reducing triglyceride levels

FDA approval for Rebetol in pediatric hepatitis C

Antiemetic properties reported for known analgesic agent

Novel, more stable compositions of statin claimed

Bisphosphonates: methods for treatment of bone disorders claimed

Factive receives expanded FDA approval

FDA approves Humatrope for short stature

Solid controlled-release formulations of known antidepressant

Compositions of dextrin sulfate for STDs claimed by ML Laboratories

Today's news in brief

Today's news in brief

By the numbers: US leads charge of cell and gene therapies

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Regulatory RSS

Regulatory
RSS